Sonia Capellero

Candiolo Cancer Institute, FPO-IRCCS

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (10)

Roberta Porporato

Candiolo Cancer Institute, FPO-IRCCS

ITALY

View details

Giorgio Valabrega

University of Turin

ITALY

View details

Valeria Leuci

Candiolo Cancer Institute

ITALY

View details

Maria Flavia DI RENZO

Full professor

Università degli Studi di Torino

ITALY

View details

Tiziana Venesio

Candiolo Cancer Institute, FPO-IRCCS

ITALY

View details

Enzo Medico

Full Professor

University of Turin

ITALY

View details

Dario Sangiolo

University of Turin

ITALY

View details

Elisa Vigna

Candiolo Cancer Institute

ITALY

View details

Ymera Pignochino

Assistant Professor

University of Turin

ITALY

View details

GIULIA MESIANO

Candiolo Cancer Institute, FPO-IRCCS

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sonia Capellero

Research Interests

Explore related searches

Contact this professor

Articles (10)

Full chimaeric CAR.CIK from patients engrafted after allogeneic haematopoietic cell transplant: Feasibility, anti-leukaemic potential and alloreactivity across major human leukocyte antigen barriers

Full chimaeric CAR.CIK from patients engrafted after allogeneic haematopoietic cell transplant: Feasibility, anti-leukaemic potential and alloreactivity across major human leukocyte antigen barriers.

Ovarian Cancer Cells in Ascites Form Aggregates That Display a Hybrid Epithelial-Mesenchymal Phenotype and Allows Survival and Proliferation of Metastasizing Cells

Ovarian Cancer Cells in Ascites Form Aggregates That Display a Hybrid Epithelial-Mesenchymal Phenotype and Allows Survival and Proliferation of Metastasizing Cells

Cancer Cells Haploinsufficient for ATM Are Sensitized to PARP Inhibitors by MET Inhibition

CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes.

Preclinical immunotherapy with Cytokine-Induced Killer lymphocytes against epithelial ovarian cancer.

PIK3R1W624R Is an Actionable Mutation in High Grade Serous Ovarian Carcinoma.

CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes

PIK3R1W624R Is an Actionable Mutation in High Grade Serous Ovarian Carcinoma

Collaborators (10)

Roberta Porporato

Giorgio Valabrega

Valeria Leuci

Maria Flavia DI RENZO

Tiziana Venesio

Enzo Medico

Dario Sangiolo

Elisa Vigna

Ymera Pignochino

GIULIA MESIANO

Make your next move.